Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors

    NEXT STORY
    Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference
    PREV STORY
    The global medical headwalls market is expected to reach US$ 1,318.68 Mn in 2027 from US$ 826.80 Mn in 2018
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Manuscript Describes How TLC’s Inhalable Liposomal Hydroxychloroquine May Provide Clinical Benefit and Serve as Potential Treatment for COVID-19

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Biocartis to host webcast for announcement 2017 financial results on 1 March 2018

      PRESS RELEASE: REGULATED INFORMATION 22 February 2018, 07:00 CET BioCARTIS to Host Webcast FOR ...

    author_avatar
    NASDAQ Market News

    Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care

    author_avatar
    NASDAQ Market News